Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
6–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of Juvenile Rheumatoid Arthritis or Juvenile Idiopathic Arthritis;
Current active arthritis;
Failed treatment with at least one disease modifying anti-rheumatic drug (DMARD);
Subjects must discontinue use of any DMARD other than methotrexate prior to the first dose of study medication
You may not be if
Presence of infection or history of frequent acute or chronic infections;
Joint replacement surgery required during the study or history of surgery on more than 5 joints;
Live vaccines within 3 months of the first dose of study medication;
Unresolved serious bacterial infection or chronic bacterial infection;
Subjects who currently have intermittent fever due to JRA/JIA, rheumatoid rash, hepato-splenomegaly, pleuritis, pericarditis, or macrophage activation syndrome.
Clareo Health | BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
